Last Updated: June 17, 2026

Suppliers and packagers for HAILEY FE 1.5/30

✉ Email this page to a colleague

« Back to Dashboard

HAILEY FE 1.5/30

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Glenmark Speclt	HAILEY FE 1.5/30	ethinyl estradiol; norethindrone acetate	TABLET;ORAL-28	209031	ANDA	Glenmark Pharmaceuticals Inc., USA	68462-503-29	3 POUCH in 1 CARTON (68462-503-29) / 1 BLISTER PACK in 1 POUCH (68462-503-84) / 1 KIT in 1 BLISTER PACK	2018-06-05
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Suppliers and packagers for HAILEY FE 1.5/30

Last updated: June 16, 2026

Hailey FE 1.5/30 suppliers (ethinyl estradiol and norethindrone acetate tablets): who manufactures and supplies

Executive summary: No complete, verifiable supplier/manufacturer list for Hailey FE 1.5/30 can be produced from the information provided.

Who manufactures Hailey FE 1.5/30 (ethinyl estradiol and norethindrone acetate tablets)?

Answer: Not determinable from the provided inputs.

What label entities are typically suppliers for Hailey FE 1.5/30?

Marketing authorization holder / NDA holder
Tablet manufacturer(s) listed on FDA labeling
Primary packager / secondary packaging site
Labeler on the drug label (if different from NDA holder)
Distribution and wholesaler network

What companies supply Hailey FE 1.5/30 to US wholesalers and pharmacies?

Answer: Not determinable from the provided inputs.

Which distribution models apply to Hailey FE 1.5/30?

Direct-to-wholesaler supply
Contract manufacturing with separate labeler
Regional wholesaler distribution arrangements

What is the Orange Book status of Hailey FE 1.5/30, and who are the listed applicants?

Answer: Not determinable from the provided inputs.

What Orange Book fields determine supplier responsibility?

NDA holder / applicant
Listed patents and corresponding dosage forms
Exclusivity indicators (if any)

Who is the contract manufacturer for Hailey FE 1.5/30 (tablets) and what plants make it?

Answer: Not determinable from the provided inputs.

What evidence usually identifies contract manufacturers?

FDA labeling “Manufactured for…” line
FDA product listing (establishment registrations tied to the NDC)
Facility identifiers in cGMP databases

Which generic or AB-rated equivalents compete with Hailey FE 1.5/30 and do they indicate supplier overlap?

Answer: Not determinable from the provided inputs.

How supplier overlap can be inferred (when data exists)

Shared labeler across different NDCs
Same manufacturing establishment across NDA/ANDA products
Same packaging site across multiple NDCs

What FDA listing details (NDC, labeler, dosage form) map to Hailey FE 1.5/30 suppliers?

Answer: Not determinable from the provided inputs.

Key Takeaways

A supplier list for Hailey FE 1.5/30 cannot be compiled from the information provided.
Determining suppliers requires verified mapping from NDC/labeler and FDA labeling to the actual manufacturing and packaging establishments.

FAQs

What does “Hailey FE 1.5/30” correspond to in NDC terms?
How do I identify the labeler and manufacturer from Hailey FE package labeling?
Does Hailey FE 1.5/30 have multiple manufacturing sites for the tablets?
Do different NDCs for Hailey FE 1.5/30 share the same supplier?
Where in FDA product data can supplier entities be confirmed for Hailey FE?

More… ↓

⤷ Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.